Search
for
Sort by
Research 391–420 of 1000+
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Hyper-Androgenic Symptoms and Infertility in Northern Upper Egypt: Impact of Lifestyle Modification
- A different approach to PCOS: evaluation of spermiogram results in male patients with a family history of PCOS
- An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil
- Improvement of androgenic alopecia by extracellular vesicles secreted from hyaluronic acid-stimulated induced mesenchymal stem cells
- Androgenic alopecia is associated with higher dietary inflammatory index and lower antioxidant index scores
- Oral Supplementation with l-Cystine, <i>Serenoa repens</i>, <i>Cucurbita pepo</i>, and <i>Pygeum africanum</i> in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study
- Injectable platelet-rich fibrin for treatment of female pattern hair loss
- The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology
- A New Office Based Protocol to Reverse AGA Miniaturization at Early and Advanced Stages
- Effectiveness and Safety of Hair Growth Formulation Containing <i>Tectona grandis</i> L.f (Teak) Leaf Extract: A Randomized, Double-Blind, Placebo-Controlled Study on Males with Androgenic Alopecia
- Efficacy and safety of topical 3% minoxidil for facial hair enhancement in transmen: a randomized, double-blind, placebo-controlled trial
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- Potential Therapeutic Targets for Androgenetic Alopecia (AGA) in Obese Individuals as Revealed by a Gut Microbiome Analysis: A Mendelian Randomization Study
- Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering
- Polycystic ovary syndrome
- Female Pattern Hair Loss: a clinical and pathophysiological review
- Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
- Testosterone therapy in women: Myths and misconceptions
- Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia
- Distribution of Body Hair in Young Australian Women and Associations With Serum Androgen Concentrations
- Proopiomelanocortin (POMC) and Psychodermatology
- Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- Higher Levels of Serum Uric Acid Have a Significant Association with Lower Incidence of Lower Urinary Tract Symptoms in Healthy Korean Men
- Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome
- Depression in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- The Use of Anabolic Steroids by Bodybuilders in the State of Sergipe, Brazil
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia